Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Second Primary Malignancies and Cardiovascular Mortality in Hodgkin disease Survivors — a Surveillance, Epidemiology, and End Results Registry Database Study

Upama Giri, Kruti Patel, DO, Michael G. Martin, MD

Blood (2017) 130 (Supplement 1): 1513.

https://doi.org/10.1182/blood.V130.Suppl_1.1513.1513

Published: 2017

Journal Articles

T-Cell Replete Peripheral Blood Haploidentical Transplant Using Immunogenic Dose of Cyclophosphamide with Fludarabine and Melphalan Results in Enhanced Cytokine Release Syndrome (CRS) with Robust Immune Recovery and Low Relapse Rates

Yasser Khaled, MD, Jason C. Chandler, MD, Joshua Boss, RN, OCN, Arnel Pallera, MD, Michael G. Martin, MD, Robert Bradley, MD, Robert Johnson, MD

Blood (2017) 130 (Supplement 1): 1934.

https://doi.org/10.1182/blood.V130.Suppl_1.1934.1934

Published: 2017

Journal Articles

Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma

Eric Vick, PhD, Kruti Patel, DO, Noah Richardson, BA, Taylor Alloway, MD, Glenda M Delgado Ramos, MD, Alaa Altahan, MD, Michael G. Martin, MD

Blood (2017) 130 (Supplement 1): 1571.

https://doi.org/10.1182/blood.V130.Suppl_1.1571.1571

Published: 2017

Journal Articles

Survival Outcomes in Grade 3 Follicular Lymphoma Prior to and after the Introduction of Rituximab - an Analysis Based on the Surveillance, Epidemiology, and End Result Registry Database

Upama Giri, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 2967.

https://doi.org/10.1182/blood.V128.22.2967.2967

Published: 2016

Journal Articles

Clinical Trial Availability in Adolescent and Young Adult Patients with Non-Hodgkin Lymphoma

Melissa Ann Crawley, MD, Matthew K Stein, MD, Kruti Patel, DO, Michael G. Martin, MD

Blood (2016) 128 (22): 5937.

https://doi.org/10.1182/blood.V128.22.5937.5937

Published: 2016

Journal Articles

Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma

Namratha R Vontela, MD, Kenneth Byrd, Brennan McCullar, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 5399.

https://doi.org/10.1182/blood.V128.22.5399.5399

Published: 2016

Journal Articles

Genetic Analysis of B-Cell Lymphomas Associated with Hemophagocytic Lymphohistiocytosis (HLH)

Kruti Patel, DO, Sophia S Lee, Poojitha Valasareddy, MD, Namratha R Vontela, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 5315.

https://doi.org/10.1182/blood.V128.22.5315.5315

Published: 2016

Journal Articles

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Matthew K Stein, MD, Dilan Patel, MD, Andrew Hahn, MD, Jamie Riney, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1935.

https://doi.org/10.1182/blood.V128.22.1935.1935

Published: 2016

Journal Articles

Distribution of 9p24 Abnormalities in Hematologic Malignancies with an Emphasis on Diffuse Large B-Cell Lymphoma

Dilan Patel, MD, Jamie Riney, MD, Andrew Hahn, MD, Matthew K Stein, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1866.

https://doi.org/10.1182/blood.V128.22.1866.1866

Published: 2016

Journal Articles

Final Results of a Phase 1/2 Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of Evofosfamide, a Hypoxia-Activated Prodrug, and Dexamethasone with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma

Blood (2016) 128 (22): 2122.

https://doi.org/10.1182/blood.V128.22.2122.2122

Published: 2016

Journal Articles

Therapy Related Myeloid and Lymphoid Neoplasms in BRCA Mutated Breast and Ovarian Cancer Patients

Mohammad M Mirza, MD, Brennan Mccular, MD, Michael G Martin, MD

Blood (2016) 128 (22): 5115.

https://doi.org/10.1182/blood.V128.22.5115.5115

Published: 2016

Journal Articles

The Addition of Rituximab to Chemotherapy Decreased Rates of Primary Surgery for Gastric Diffuse Large B-Cell Lymphoma without Increasing Early Mortality

Eric Wiedower, DO, Smith Giri, MBBS, Andrew Fintel, DO, Philip Prouet, MD, Elena Paulus, MD, Jason C. Chandler, MD, Mike G. Martin, MD

Blood (2015) 126 (23): 4475.

https://doi.org/10.1182/blood.V126.23.4475.4475

Published: 2015

Journal Articles

Outcome of Adolescents and Young Adults with Acute Myeloid Leukemia (AML) As Compared to Pediatric AML Patients: Real World Data from SEER Registry

Smith Giri, MBBS, Nunnery Sara, Syed S. Nasir, Michael G Martin, MD

Blood (2015) 126 (23): 4484.

https://doi.org/10.1182/blood.V126.23.4484.4484

Published: 2015

Journal Articles

Comorbidities Drive Outcomes for Both Malignancy and Non-Malignancy Associated Hemophagocytic Syndrome

Benny Johnson, DO, Smith Giri, MBBS, Sara E. Nunnery, Eric Wiedower, DO, Omer Jamy, MD, Jason C. Chandler, MD, Mike G. Martin, MD

Blood (2015) 126 (23): 3261.

https://doi.org/10.1182/blood.V126.23.3261.3261

Published: 2015

Journal Articles

Under-Recognition of Hemophagocytic Lymphohistiocytosis in United States' Rural, Non-Teaching Hospitals

Omer Jamy, MD, Eric Wiedower, DO, Smith Giri, MBBS, Benny Johnson, DO, Sara E. Nunnery, Mike G. Martin, MD

Blood (2015) 126 (23): 2079.

https://doi.org/10.1182/blood.V126.23.2079.2079

Published: 2015

Journal Articles

Multigene MRD Assessment Improves AML Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation

Matthew P. Mulé, BS, Gabriel N. Mannis, MD, Jerald P. Radich, MD, Brent L. Wood, MDPhD, Nestor R. Ramos, MD, Catherine E. Lai, MD, Michael Flanders, BA, Charalambos Andreadis, MD MSCE, Lloyd E. Damon, MD, Aaron C. Logan, MDPhD, Thomas G. Martin, MD, Christopher S. Hourigan, MDPhD

Blood (2015) 126 (23): 4350.

https://doi.org/10.1182/blood.V126.23.4350.4350

Published: 2015

Journal Articles

A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Thomas G. Martin, MD, Rachid Baz, MD, Don M. Benson, MD PhD, Nikoletta Lendvai, MD PhD, Frank Campana, MD, Eric Charpentier, Ravi Vij, MBBS, MD

Blood (2014) 124 (21): 83.

https://doi.org/10.1182/blood.V124.21.83.83

Published: 2014

Journal Articles

Acute Megakaryocytic Leukemia (AMegL) Is Associated with Inferior Outcomes Relative to Other Acute Myeloid Leukemia (AML) Morphologies

Smith Giri, MD, Michael G Martin, MD, Ranjan Pathak, MD, Bojia Li, MD, Philippe E Prouet

Blood (2014) 124 (21): 2285.

https://doi.org/10.1182/blood.V124.21.2285.2285

Published: 2014

Journal Articles

KIR and HLA Genotypes Influence Clinical Outcome in Multiple Myeloma Patients Treated with SAR650984 (Anti-CD38) in Combination with Lenalidomide and Dexamethasone

John Marra, BS, Juan Du, MD PhD, Jimmy Hwang, PhD, Jeffrey L Wolf, MD, Thomas G. Martin, MD, Jeffrey M Venstrom, MD

Blood (2014) 124 (21): 2126.

https://doi.org/10.1182/blood.V124.21.2126.2126

Published: 2014

Journal Articles

Updated Results from a Phase 2 Extension Study of Patients with Multiple Myeloma or Solid Tumors Previously Enrolled in Carfilzomib Company-Sponsored Phase 1 and 2 Clinical Trials (PX-171-010)

David S. Siegel, MD PhD, Jesus G. Berdeja, MD, Jeffrey R. Infante, MD, Jonathan L. Kaufman, MD, Michael (Luhua) Wang, MD, Thomas G. Martin, MD, Ruben Niesvizky, MD, Frederic J. Reu, MD, Sundar Jagannath, MD, Kanya Rajangam, MDPhD, Mei Huang, MS, Ravi Vij, MD

Blood (2014) 124 (21): 2134.

https://doi.org/10.1182/blood.V124.21.2134.2134

Published: 2014

NARROW

Second Primary Malignancies and Cardiovascular Mortality in Hodgkin disease Survivors — a Surveillance, Epidemiology, and End Results Registry Database Study

T-Cell Replete Peripheral Blood Haploidentical Transplant Using Immunogenic Dose of Cyclophosphamide with Fludarabine and Melphalan Results in Enhanced Cytokine Release Syndrome (CRS) with Robust Immune Recovery and Low Relapse Rates

Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma

Survival Outcomes in Grade 3 Follicular Lymphoma Prior to and after the Introduction of Rituximab - an Analysis Based on the Surveillance, Epidemiology, and End Result Registry Database

Clinical Trial Availability in Adolescent and Young Adult Patients with Non-Hodgkin Lymphoma

Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma

Genetic Analysis of B-Cell Lymphomas Associated with Hemophagocytic Lymphohistiocytosis (HLH)

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Distribution of 9p24 Abnormalities in Hematologic Malignancies with an Emphasis on Diffuse Large B-Cell Lymphoma

Final Results of a Phase 1/2 Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of Evofosfamide, a Hypoxia-Activated Prodrug, and Dexamethasone with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma

Therapy Related Myeloid and Lymphoid Neoplasms in BRCA Mutated Breast and Ovarian Cancer Patients

The Addition of Rituximab to Chemotherapy Decreased Rates of Primary Surgery for Gastric Diffuse Large B-Cell Lymphoma without Increasing Early Mortality

Outcome of Adolescents and Young Adults with Acute Myeloid Leukemia (AML) As Compared to Pediatric AML Patients: Real World Data from SEER Registry

Comorbidities Drive Outcomes for Both Malignancy and Non-Malignancy Associated Hemophagocytic Syndrome

Under-Recognition of Hemophagocytic Lymphohistiocytosis in United States' Rural, Non-Teaching Hospitals

Multigene MRD Assessment Improves AML Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation

A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Acute Megakaryocytic Leukemia (AMegL) Is Associated with Inferior Outcomes Relative to Other Acute Myeloid Leukemia (AML) Morphologies

KIR and HLA Genotypes Influence Clinical Outcome in Multiple Myeloma Patients Treated with SAR650984 (Anti-CD38) in Combination with Lenalidomide and Dexamethasone

Updated Results from a Phase 2 Extension Study of Patients with Multiple Myeloma or Solid Tumors Previously Enrolled in Carfilzomib Company-Sponsored Phase 1 and 2 Clinical Trials (PX-171-010)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only